{"id":"W2296942186","doi":"10.1200/jco.2015.33.18_suppl.lba502","title":"PALOMA3: A double-blind, phase III trial of fulvestrant with or without palbociclib in pre- and post-menopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Palbociclib; Medicine; Metastatic breast cancer; Internal medicine; Goserelin; Clinical endpoint; Oncology; Breast cancer; Interim analysis; Tolerability; Cancer; Gynecology; Tamoxifen; Clinical trial; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381153,0.001846888,0.001766004,0.0005216723,0.0004484056,0.0009588936,0.001521309,0.001804861,0.007478404],"category_scores_gemma":[0.001165734,0.000676115,0.001341889,0.0004308825,0.001464796,0.0009394094,0.0004372936,0.003305307,0.001341912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006882302,"about_ca_system_score_gemma":0.001966469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069728,"about_ca_topic_score_gemma":0.00282419,"domain_scores_codex":[0.9996853,0.0001442511,0.00001496525,0.00004898324,0.000027491,0.00007892443],"domain_scores_gemma":[0.9994418,0.0001254566,0.0001088457,0.00004464334,0.00003387417,0.0002453142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9451098,0.01914075,0.0006571796,0.0005481988,0.0003555813,0.00008280788,0.00008896673,0.0004723007,0.008655376,0.0001752154,0.001763311,0.02295055],"study_design_scores_gemma":[0.9370239,0.06039947,0.001110654,0.00001499613,0.00009391439,0.00004590517,0.00001620094,0.0002857588,0.0004278404,0.0001094534,0.0004630592,0.000008784865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820209,0.002695319,0.0008705953,0.0009136638,0.0003702338,0.007538568,0.00219032,0.0003728164,0.003027577],"genre_scores_gemma":[0.9772645,0.002036006,0.001610223,0.001435483,0.0003002806,0.009325309,0.0024579,0.00004992539,0.005520273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007478404,"threshold_uncertainty_score":0.0250178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1249024538445055,"score_gpt":0.4693961585716095,"score_spread":0.344493704727104,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}